期刊文献+
共找到1,197篇文章
< 1 2 60 >
每页显示 20 50 100
Propofol sedation in routine endoscopy:A case series comparing target controlled infusion vs manually controlled bolus concept
1
作者 Riad Sarraj Lorenz Theiler +2 位作者 Nima Vakilzadeh Niklas Krupka Reiner Wiest 《World Journal of Gastrointestinal Endoscopy》 2024年第1期11-17,共7页
BACKGROUND Many studies have addressed safety and effectiveness of non-anaesthesiologist propofol sedation(NAPS)for gastrointestinal(GI)endoscopy Target controlled infusion(TCI)is claimed to provide an optimal sedatio... BACKGROUND Many studies have addressed safety and effectiveness of non-anaesthesiologist propofol sedation(NAPS)for gastrointestinal(GI)endoscopy Target controlled infusion(TCI)is claimed to provide an optimal sedation regimen by avoiding under-or oversedation.AIM To assess safety and performance of propofol TCI sedation in comparison with nurse-administered bolus-sedation.METHODS Fouty-five patients undergoing endoscopy under TCI propofol sedation were prospectively included from November 2016 to May 2017 and compared to 87 patients retrospectively included that underwent endoscopy with NAPS.Patients were matched for age and endoscopic procedure.We recorded time of sedation and endoscopy,dosage of medication and adverse events.RESULTS There was a significant reduction in dose per time of propofol administered in the TCI group,compared to the NAPS group(8.2±2.7 mg/min vs 9.3±3.4 mg/min;P=0.046).The time needed to provide adequate sedation levels was slightly but significantly lower in the control group(5.3±2.7 min vs 7.7±3.3 min;P<0.001),nonetheless the total endoscopy time was similar in both groups.No differences between TCI and bolus-sedation was observed for mean total-dosage of propofol rate as well as adverse events.CONCLUSION This study indicates that sedation using TCI for GI endoscopy reduces the dose of propofol necessary per minute of endoscopy.This may translate into less adverse events.However,further and randomized trials need to confirm this trend. 展开更多
关键词 SEDATION ENDOSCOPY PROPOFOL target controlled infusion Non-anaesthesiologist propofol sedation Adverse event
下载PDF
Propofol Target-Controlled Infusion Modeling in Rabbits:Pharmacokinetic and Pharmacodynamic Analysis 被引量:2
2
作者 陈建颜 易明 +1 位作者 姚尚龙 张雪萍 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2016年第3期428-433,共6页
This study aimed to establish a new propofol target-controlled infusion(TCI) model in animals so as to study the general anesthetic mechanism at multi-levels in vivo. Twenty Japanese white rabbits were enrolled and ... This study aimed to establish a new propofol target-controlled infusion(TCI) model in animals so as to study the general anesthetic mechanism at multi-levels in vivo. Twenty Japanese white rabbits were enrolled and propofol(10 mg/kg) was administrated intravenously. Artery blood samples were collected at various time points after injection, and plasma concentrations of propofol were measured. Pharmacokinetic modeling was performed using Win Nonlin software. Propofol TCI within the acquired parameters integrated was conducted to achieve different anesthetic depths in rabbits, monitored by narcotrend. The pharmacodynamics was analyzed using a sigmoidal inhibitory maximal effect model for narcotrend index(NI) versus effect-site concentration. The results showed the pharmacokinetics of propofol in Japanese white rabbits was best described by a two-compartment model. The target plasma concentrations of propofol required at light anesthetic depth was 9.77±0.23 μg/m L, while 12.52±0.69 μg/m L at deep anesthetic depth. NI was 76.17±4.25 at light anesthetic depth, while 27.41±5.77 at deep anesthetic depth. The effect-site elimination rate constant(ke0) was 0.263/min, and the propofol dose required to achieve a 50% decrease in the NI value from baseline was 11.19 μg/m L(95% CI, 10.25–13.67). Our results established a new propofol TCI animal model and proved the model controlled the anesthetic depth accurately and stably in rabbits. The study provides a powerful method for exploring general anesthetic mechanisms at different anesthetic depths in vivo. 展开更多
关键词 propofol target-controlled infusion modeling rabbit pharmacokinetics pharmacodynamics anesthetic depth
下载PDF
Target-controlled Infusion of Propofol and Remifentanil for a patient with Ablation of Atrial Fibrillation
3
作者 Su-min Gao Zheng-chao Yang Ting-ting Wang Shang-long Yao 《麻醉与监护论坛》 2014年第1期69-72,共4页
关键词 芬太尼 异丙酚 患者 颤动 心房 麻醉技术 评估标准 安全性
下载PDF
CONCERT-CL闭环靶控输注系统对腹腔镜胃肠手术患者术后胃肠功能及免疫功能的影响
4
作者 王芳琪 雷林军 +3 位作者 付茂璟 魏子钦 王晓敏 谢妍 《海南医学》 CAS 2024年第5期641-645,共5页
目的 探讨CONCERT-CL闭环靶控输注系统在腹腔镜胃肠手术患者中的应用效果及对患者术后胃肠功能和免疫功能的影响。方法 选取2022年8月至2023年5月上海市徐汇区中心医院收治的80例腹腔镜胃肠手术患者作为研究对象,按随机数表法分为观察... 目的 探讨CONCERT-CL闭环靶控输注系统在腹腔镜胃肠手术患者中的应用效果及对患者术后胃肠功能和免疫功能的影响。方法 选取2022年8月至2023年5月上海市徐汇区中心医院收治的80例腹腔镜胃肠手术患者作为研究对象,按随机数表法分为观察组和对照组各40例。两组患者均采用相同的麻醉方案,但观察组患者采用CONCERT-CL闭环靶控输注系统进行麻醉管理,而对照组患者则采用开放式麻醉维持。比较两组患者的围术期相关指标、胃肠功能和围术期白细胞分化抗原(CD) TT细胞数量和自然杀伤细胞(NK)细胞数量,同时比较两组患者术后不良反应发生情况。结果 观察组患者的手术时间、麻醉时间分别为(183.60±30.15) min、(206.69±10.54) min,对照组分别为(189.12±43.85) min、(211.65±16.83) min,差异均无统计学意义(P>0.05);观察组患者术中丙泊酚用量和顺式阿曲库铵用量分别为(13.34±2.00) mg/kg、(0.26±0.09) mg/kg,明显低于对照组的(15.96±1.41) mg/kg、(0.35±0.11) mg/kg,拔管即刻警觉-镇静(OAA/S)评分和术中BIS时间为40~60的占比分别为(3.46±0.25)分、(82.60±4.22)%,明显高于对照组的(3.12±0.46)分、(64.02±3.65)%,差异均有统计学意义(P<0.05);观察组和对照组患者的肠鸣音恢复[(22.60±4.52) h vs (30.57±6.84) h]、腹痛缓解[(26.88±4.11) h vs (30.17±2.94) h]、术后首次排气时间[(32.69±4.25) h vs (44.35±1.68) h]比较,观察组明显短于对照组,差异均有统计学意义(P<0.05);术后12 h,观察组和对照组患者的CD4+TT数量[(35.69±1.54)%vs (32.01±6.21)%]、NK细胞数量[(20.36±2.41)%vs (18.73±2.65)%]比较,观察组明显高于对照组,CD8+TT数量[(27.01±1.79)%vs (29.28±3.87)%]比较,观察组明显低于对照组,差异均有统计学意义(P<0.05);观察组患者的不良反应总发生率为5.00%,略低于对照组的10.00%,但差异无统计学意义(P>0.05)。结论 CONCERT-CL闭环靶控输注系统在腹腔镜胃肠手术患者中的应用能够降低术中麻醉维持药物用量,患者苏醒速度更快。同时还能够促进患者术后胃肠功能的恢复,并且对免疫功能起到一定改善作用。 展开更多
关键词 CONCERT-CL闭环靶控输注系统 腹腔镜胃肠手术 麻醉患者 胃肠功能 免疫功能
下载PDF
靶控输注-全凭静脉麻醉与静吸复合麻醉对老年患者术后认知功能的影响
5
作者 万福林 《中外医药研究》 2024年第21期19-21,共3页
目的:分析靶控输注-全凭静脉麻醉(TCI-TIVA)与静吸复合麻醉对老年患者术后认知功能的影响。方法:选取2021年1月—2023年10月于遵义市播州区人民医院接受全身麻醉手术的老年患者80例作为研究对象,利用随机数字表法分为研究组(TCI-TIVA)... 目的:分析靶控输注-全凭静脉麻醉(TCI-TIVA)与静吸复合麻醉对老年患者术后认知功能的影响。方法:选取2021年1月—2023年10月于遵义市播州区人民医院接受全身麻醉手术的老年患者80例作为研究对象,利用随机数字表法分为研究组(TCI-TIVA)与对照组(静吸复合麻醉),各40例。比较两组麻醉效果、术后认知情况及不良反应发生率。结果:研究组苏醒、自主呼吸恢复、拔管、定向力恢复时间均短于对照组,差异有统计学意义(P<0.001);术后3、6、12 h,两组简易智力状态检查量表(MMSE)评分均低于诱导前,研究组MMSE评分高于对照组,差异有统计学意义(P<0.05);研究组苏醒期不良反应发生率低于对照组,差异有统计学意义(P=0.021)。结论:在老年患者术中应用TCI-TIVA的效果优于静吸复合麻醉,可促进患者自主呼吸、定向力恢复,苏醒时间更短,拔管时间更早,且对患者术后认知功能的影响较小,麻醉安全性较高。 展开更多
关键词 静吸复合麻醉 靶控输注-全凭静脉麻醉 术后认知功能障碍
下载PDF
Two-stage analysis of pharmacokinetics of sufentanil administered by target-controlled infusion in Chinese patients 被引量:16
6
作者 ZHAO Yan DUAN Jing-li +9 位作者 WU Xin-min JIANG Jian-yu LU Wei ZHANG Li-ping WANG Jun MENG Xiu-li XU Chuan-ya JIA Dong-lin LIU Wei SHENG Xiao-yan 《Chinese Medical Journal》 SCIE CAS CSCD 2009年第17期1979-1984,共6页
Background Sufentanil is a suitable choice for target-controlled infusion (TCI) because of its shorter context-sensitive half-time. The current study was to estimate the pharmacokinetics of sufentanil TCI in Chinese... Background Sufentanil is a suitable choice for target-controlled infusion (TCI) because of its shorter context-sensitive half-time. The current study was to estimate the pharmacokinetics of sufentanil TCI in Chinese patients using the two-stage analysis. Methods Twelve adult patients with American Society of Anesthesiologists (ASA) physical status I or II undergoing elective surgery under general anesthesia were included. Anesthesia was induced with propofol, rocuronium and sufentanil administered by TCI lasting for 30 minutes, with target effect-site concentration of sufentanil 4 or 6 ng/ml. Frequent arterial blood samples (1.5 ml) were taken during and up to 24 hours after sufentanil TCI. Before the end of surgery, another arterial blood sample (1.0 ml) was drawn for the blood-gas analysis. Plasma sufentanil concentrations were determined by liquid chromatography-tandem mass spectrometry (limit of quantitation was 5 pg/ml). The data were analyzed with the two-stage approach, linear regression and correlation analysis. Results The pharmacokinetics of sufentanil TCI were adequately described by a three-compartment model. The variables were derived as follows: the volume of central compartment (V1) was 5.4 L, volume of distribution at steady-state (Vdss) was 222.6 L, metabolic clearance (CI1) was 0.84 L/min and elimination half-life (t~/2y) was 389 minutes. Patients' age, gender and PaCO2 correlated significantly with the pharmacokinetic parameters. The Vdss, volume of slowly equilibrating compartment (V3) and t1/2 y increased, and rapid distribution clearance (012) decreased with increasing patient age. Male patients had larger values of Vdss, volume of rapidly equilibrating compartment (V2) and V3 than female patients. The Vdss and V3 increased with higher PaCO2 values. There were no significant correlations between the pharmacokinetic variables and body weight, height, lean body mass, plasma albumin, sufentanil dose, duration of surgery, pH or base excess of blood (BE-B). Conclusions The pharmacokinetics of sufentanil TCI in Chinese patients can be optimally described by a three-compartment model. The pharmacokinetic analysis technique may affect the pharmacokinetic parameters and correlations. 展开更多
关键词 ANESTHESIA SUFENTANIL PHARMACOKINETICS target-controlled infusion two-stage analysis
原文传递
Pharmacokinetics of sufentanil administered by target-controlled infusion in Chinese surgical patients 被引量:32
7
作者 ZHAO Yan WU Xin-min +5 位作者 DUAN Jing-li SHENG Xiao-yan LIU Wei LU Wei ZHANG Li-ping XU Chuan-ya 《Chinese Medical Journal》 SCIE CAS CSCD 2009年第3期291-295,共5页
Background Target-controlled infusion (TCI) has been recently developed and successfully implemented in clinical practice. This study was conducted to determine the pharmacokinetics of TCI administered sufentanil in... Background Target-controlled infusion (TCI) has been recently developed and successfully implemented in clinical practice. This study was conducted to determine the pharmacokinetics of TCI administered sufentanil in Chinese surgical patients. Methods The pharmacokinetics of sufentanil was investigated in 12 adult patients, aged 23-76 years, scheduled for prolonged surgery under general anesthesia. Anesthetic induction was carried out with propofol, rocuronium and TCI administered sufentanil aiming for target effect-site concentration of sufentanil 4 or 6 ng/ml. Sufentanil TCI lasted for 30 minutes. Frequent arterial blood samples (1.5 ml) were drawn during and up to 24 hours after sufentanil TCI. Plasma sufentanil concentrations were measured by liquid chromatography-tandem mass spectrometry; limit of sensitivity of mass spectrometry was 5 pg/ml. The data were analyzed with the nonlinear mixed-effect model program. Results The pharmacokinetics of TCI administered sufentanil were optimally described by a three-compartment model with the following parameters: the central volume of distribution (V1) = 5.4 L, the volume of distribution at steady-state (Vdss) = 195.4 L, systemic clearance (CI1) = 1.10 L/min, and elimination half-life (t1/2 Y) = 271.8 minutes. Both age and gender affected the pharmacokinetic parameters. The rapid distribution clearance (012) was negatively correlated with patient age, and the volume of slowly equilibrating compartment (V3) was positively correlated with age. The Cl2 and the volume of rapidly equilibrating compartment (V2) were influenced by gender with male patients showing higher values of Cl2 and V2 than female patients. There was no relationship of body weight, lean body mass, plasma albumin, or target effect-site concentration of sufentanil with any of the pharmacokinetic parameters studied. Conclusions The pharmacokinetics of TCI administered sufentanil in Chinese patients can be adequately described by a three-compartment model. Pharmacokinetics adjusted to the individual patient should improve the accuracy of TCI systems. 展开更多
关键词 SUFENTANIL PHARMACOKINETICS target-controlled infusion tandem mass spectrometry mixed-effect model
原文传递
Relationship between depth of anesthesia and effect-site concentration of propofol during induction with the target-controlled infusion technique in elderly patients 被引量:24
8
作者 LIU Shao-hua WEI Wei DING Guan-nan KE Jing-dong HONG Fang-xiao TIAN Ming 《Chinese Medical Journal》 SCIE CAS CSCD 2009年第8期935-940,共6页
Background There are few studies to assess whether the effect-site concentration of propofol can predict anesthetic depth during the target-controlled infusion (TCI) induction in elderly patients. This study aimed t... Background There are few studies to assess whether the effect-site concentration of propofol can predict anesthetic depth during the target-controlled infusion (TCI) induction in elderly patients. This study aimed to evaluate the relationship between effect-site concentration of propofol and depth of anesthesia during the TCI induction in elderly patients. Methods Ninety patients (60-80 years) with an American Society of Anesthesiologists (ASA) physical status of 1-3, undergoing scheduled abdominal and thoracic surgery under general anesthesia were randomly allocated into one of three groups, Group S1, S2 and S3 (30 patients in each group). The patients in Group S1 received propofol with a target plasma concentration of 4.0 pg/ml; patients in Group S2 received propofol with an initial target plasma concentrations of 2.0 IJg/ml that was raised to 4.0 pg/ml 3 minutes later; patients in Group S3 received an infused scheme of 3 steps; starting from a target plasma concentration of 2.0 pg/ml that was increased stepwised by 1 pg/ml until a target plasma concentration of 4.0 pg/ml was achieved, the interval between the two steps was 3 minutes. When an Observer's Assessment of Alertness/Sedation (OANS) score of 1 was achieved, remifentanil (effect-site concentration (Ce) of 4.0 ng/ml) and rocuronium 0.9 mg/kg were administered. Tracheal intubation was started 2 minutes after rocuronium injection. Changes of propofol Ce, blood pressure (BP), heart rate (HR), and bispectral index (BIS) were recorded. Results When an OAA/S score of 1 was achieved, Ce of propofol were (1.7±0.4) pg/ml, (1.9±0.3) pg/ml, (1.9±0.4) pg/ml and the BIS values were 64±5, 65±8, and 62±8 in Groups S1, S2 and S3. Before intubation, Ce of propofol was (2.8±0.2) pg/ml, (2.8±0.3) pg/ml, (2.7±0.3) pg/ml, and the BIS values were 48±7, 51±7, and 47±5 in Groups S1, S2 and S3. By linear regression analysis, a significant correlation between Ce of propofol and BIS values was found (r=-0.580, P 〈0.01). Systolic blood pressure (SBP) before intubation was significantly lower in Group S1 than in Groups S2 and S3. SBP and HR after intubation in the three groups were significantly increased when compared with pre-intubation values, but they did not exceed baseline values Conclusions During the TCI induction, Ce of propofol with (1.9±0.3) pg/ml may make the elderly patients unconscious. When remifentanil with a Ce of 4.0 ng/ml is added a Ce of propofol with (2.8±0.3) pg/ml is suitable for intubation. The Ce of propofol has a close correlation with the BIS values. Also, a two-step TCI technique seems to be a more suitable method of anesthesia induction in elderly patients compared with the no-stepwise TCI technique and three-step TCI technique. 展开更多
关键词 PROPOFOL target-controlled infusion depth of anesthesia effect-site concentration elderly patients
原文传递
Comparison of C50 for Propofol-remifentanil Target-controlled Infusion and Bispectral Index at Loss of Consciousness and Response to Painful Stimulus in Elderly and Young Patients 被引量:12
9
作者 Ning Yang Ming-Zhang Zuo +3 位作者 Yun Yue Yun Wang Yu Shi Xue-Na Zhang 《Chinese Medical Journal》 SCIE CAS CSCD 2015年第15期1994-1999,共6页
Background:In this prospective randomized study,we compared the predicted blood and effect-site C50 for propofol and remifentanil target-controlled infusion (TCI) and the bispectral index (BIS) values at loss of ... Background:In this prospective randomized study,we compared the predicted blood and effect-site C50 for propofol and remifentanil target-controlled infusion (TCI) and the bispectral index (BIS) values at loss of consciousness (LOC) and response to a standard noxious painful stimulus (LOS) in elderly and young patients,respectively.We hypothesized that the elderly patients will require lower target concentration of both propofol and remifentanil at above two clinical end-points.Methods:There were 80 American Society of Anesthesiologists (ASA) physical status Ⅰ Ⅱ unpremedicated patients enrolled in this study,they were divided into elderly group (age ≥65 years,n =40) and young group (aged 18-54 years,n =40).Propofol was initially given to a predicted blood concentration of 1.2 μg/ml and thereafter increased by 0.3 μg/ml every 30 s until Observer's Assessment of Alertness and Sedation score was 1.The propofol level was kept constant,and remifentanil was given to provide a predict blood concentration of 2.0 ng/ml,and then increased by 0.3 ng/ml every 30 s until loss of response to a tetanic stimulus.BIS (version 3.22,BIS Quattro sensor) was also recorded.Results:In elderly group,the propofol effect-site C50 at LOC of was 1.5 (1.4-1.6) μg/ml,was significantly lower than that of young group,which was 2.2 (2.1-2.3) μg/ml,the remifentanil effect-site C50 at LOS was 3.5 (3.3-3.7) ng/ml in elderly patients,was similar with 3.7 (3.6-3.8) ng/ml in young patients.Fifty percent of patients lost consciousness at a BIS value of 57.3 (56.4-58.1),was similar with that of young group,which was 55.2 (54.0-56.3).Conclusion:In elderly patients,the predicted blood and effect-site concentrations of propofol at LOC were lower than that of young patients.At same sedation status,predicted blood and effect-site concentrations of remifentanil required at LOS were similar in elderly and young patients.BIS were not affected by age.Low-propofol/high-opioid may be optional TCI strategy for elderly patients. 展开更多
关键词 Bispectral Index Painful Stimulus Propofol-remifentanil target-controlled infusion
原文传递
Concentrations of propofol in cerebral spinal fluid: target-controlled infusion 被引量:2
10
作者 罗爱伦 易杰 +3 位作者 郭向阳 任洪智 黄宇光 叶铁虎 《Chinese Medical Journal》 SCIE CAS CSCD 2004年第2期231-234,共4页
Background Although the performance of target-controlled infusion (TCI) have been studied extensively, the accuracy and safety of a TCI system that targets the effect site remains to be demonstrated. This study was to... Background Although the performance of target-controlled infusion (TCI) have been studied extensively, the accuracy and safety of a TCI system that targets the effect site remains to be demonstrated. This study was to investigate the relations of TCI of propofol to its concentrations in cerebral spinal fluid (CSF), the effect-site concentrations and bispectral index (BIS).Methods Twelve mongrel dogs were used for investigations. The target effect-site concentration was set at 3μg/ml and the infusion was lasted for 15 minutes. CSF and blood samples were then collected and propofol concentrations were determined by using high performance liquid chromatography with fluorescence detection. BIS and hemodynamic data were monitored continuously.Results The predicted plasma concentrations were generally overestimated. Median performance error (MDPE) and absolute median performance error (MDAPE) were -10.0% and 29.9% respectively. Propofol CSF concentrations were much lower than its effect-site concentrations. Changes in BIS were consistent with propofol concentrations in CSF, both of which changed direction at 5 minutes while the effect-site concentrations relatively lagged behind. Better correlation ( r2 = 0. 9195) was found between BIS and CSF concentrations, when compared with that between BIS and effect-site concentrations (r2=0. 554).Conclusion With 1% enflurane inhaled, the inconsistency of drug effect to the effect-site concentrations may result from inaccuracy of pharmacokinetic parameters. CSF may show effect-site concentrations more accurately than plasma when using target effect-site concentration infusion. 展开更多
关键词 target-controlled infusion PROPOFOL CONCENTRATION cerebral spinal fluid
原文传递
液相色谱-质谱联用测定全身麻醉患者血浆中舒芬太尼浓度 被引量:31
11
作者 刘维 段京莉 +2 位作者 张现化 赵艳 张利萍 《中国临床药理学杂志》 CAS CSCD 北大核心 2008年第3期245-248,共4页
目的建立液相色谱质谱联用法,测定全麻患者血浆中舒芬太尼(镇痛药)浓度,并用其进行全身麻醉患者靶控输注性能的评价。方法血浆中加入内标芬太尼后,用乙腈沉淀蛋白法处理,用AgilentXDBC18色谱柱(4.6mm×150mm,5μm),乙腈-醋酸铵(10mm... 目的建立液相色谱质谱联用法,测定全麻患者血浆中舒芬太尼(镇痛药)浓度,并用其进行全身麻醉患者靶控输注性能的评价。方法血浆中加入内标芬太尼后,用乙腈沉淀蛋白法处理,用AgilentXDBC18色谱柱(4.6mm×150mm,5μm),乙腈-醋酸铵(10mmol.L-1,pH3.0)85∶15,流量为1mL·min-1。质谱用APCI离子源,正离子模式,多反应监测模式(MRM)。结果舒芬太尼在0.1~2ng.mL-1内,呈良好的线性关系,γ=0.9994。精密度及稳定性均RSD<13%。结论本法是一种简单、快速、准确、灵敏的测定舒芬太尼血药浓度的方法,可用于全身麻醉患者靶控输注性能的评价。 展开更多
关键词 舒芬太尼 液质联用 靶控输注
下载PDF
丙泊酚或异氟醚麻醉对肾素-血管紧张素系统的影响 被引量:43
12
作者 蔡宏达 杨华凌 林财珠 《临床麻醉学杂志》 CAS CSCD 2007年第2期93-95,共3页
目的比较丙泊酚靶控输注(TCI)或异氟醚吸入麻醉对肾素-血管紧张素系统(RAS)和血流动力学的影响。方法择期行胃切除手术的患者30例,ASA Ⅰ或Ⅱ级,随机分成丙泊酚TCI组(Ⅰ组)和异氟醚吸入麻醉组(Ⅱ组),每组15例。丙泊酚、芬太尼诱导后,Ⅰ... 目的比较丙泊酚靶控输注(TCI)或异氟醚吸入麻醉对肾素-血管紧张素系统(RAS)和血流动力学的影响。方法择期行胃切除手术的患者30例,ASA Ⅰ或Ⅱ级,随机分成丙泊酚TCI组(Ⅰ组)和异氟醚吸入麻醉组(Ⅱ组),每组15例。丙泊酚、芬太尼诱导后,Ⅰ组丙泊酚TCI维持麻醉,Ⅱ组异氟醚、氧化亚氮低流量吸入维持麻醉。麻醉中以听觉诱发电位(AEP)和脑电双频指数(BIS)作为麻醉深度指标,记录麻醉前(T1)、诱导插管后5min(T2)、切皮(T3)、探查(T4)、术毕拔管后5min(T5)时BP、HR、AEP、BIS、血浆肾素活性(PRA)和血管紧张素Ⅱ(AngⅡ)值。结果与T1时比较,T2时两组PRA、AngⅡ和BP均显著下降(P<0.01),T3、T4时Ⅰ组PRA显著下降,而Ⅱ组AngⅡ显著增高(P<0.01)。T3、T4时Ⅱ组PRA均显著高于Ⅰ组(P<0.01),T3、T4和T5时Ⅱ组AngⅡ显著高于Ⅰ组(P<0.05)。T4时Ⅱ组BP和HR显著高于T1时(P<0.05)。T5时Ⅰ组BIS显著低于Ⅱ组(P<0.05)。结论丙泊酚TCI可抑制RAS,应激反应轻,优于异氟醚吸入麻醉。 展开更多
关键词 丙泊酚 异氟醚 肾素-血管紧张素系统 靶控输注
下载PDF
患者自控-靶控输注系统输注舒芬太尼的准确性评价 被引量:6
13
作者 叶飞 奚彬 +4 位作者 佘守章 肖建斌 招伟贤 许立新 许学兵 《广东医学》 CAS CSCD 北大核心 2009年第2期279-281,共3页
目的通过测定舒芬太尼血药浓度的方法来评价患者自控-靶控输注(PC-TCI)系统的准确性。方法选择拟行气管内全麻下择期腹部手术的患者15例(ASAⅠ~Ⅱ级),于手术麻醉期间应用PC-TCI系统输注舒芬太尼,采用酶联免疫方法(Elisa)检测其血浆舒... 目的通过测定舒芬太尼血药浓度的方法来评价患者自控-靶控输注(PC-TCI)系统的准确性。方法选择拟行气管内全麻下择期腹部手术的患者15例(ASAⅠ~Ⅱ级),于手术麻醉期间应用PC-TCI系统输注舒芬太尼,采用酶联免疫方法(Elisa)检测其血浆舒芬太尼浓度;选择执行误差(PE)的中位数(MDPE)、PE绝对中位数(MDAPE)、分散度和摆动度作为评价其准确性的指标。结果MDPE、MDAPE、分散度、摆动度的中位数(95%可信区间)分别为-9.5%(-12.1%~-7.3%)、10.5%(7.5%~12.2%)、-2.5%/h(-6.8%/h~4.9%/h)、17.5%(10.3%~25.6%)。实测血药浓度与预测血药浓度呈线性相关(R2=0.9453)。结论患者自控-靶控输注系统的偏离度较小,精密度较高,而分散度较小,能维持较稳定的血药浓度,适合临床应用。 展开更多
关键词 舒芬太尼 药代动力学 患者控制 靶控输注
下载PDF
液相色谱-质谱联用测定罗库溴铵血药浓度及其临床应用 被引量:14
14
作者 刘维 段京莉 +1 位作者 张现化 王慧玲 《中国新药杂志》 CAS CSCD 北大核心 2008年第12期1047-1050,共4页
目的:建立液相色谱质谱联用(LC/MS/MS)测定血浆中罗库溴铵浓度的方法,并用其进行全身麻醉患者靶控输注(Target-controlled infusion,TCI)性能的评价。方法:血浆加入内标维库溴铵后用乙腈沉淀蛋白法处理,选用Atlantis Hilic Silic... 目的:建立液相色谱质谱联用(LC/MS/MS)测定血浆中罗库溴铵浓度的方法,并用其进行全身麻醉患者靶控输注(Target-controlled infusion,TCI)性能的评价。方法:血浆加入内标维库溴铵后用乙腈沉淀蛋白法处理,选用Atlantis Hilic Silica色谱柱(50 mm×2.1 mm,5μm)分离,流动相为乙腈-醋酸铵(20mmol.L-1,pH3.0)(78∶22),流速300μL.min-1。质谱用正离子模式,离子采集方式为多反应监测模式。结果:罗库溴铵在0.02~4 mg.L-1范围内呈良好的线性关系,r=0.999 2。精密度及稳定性的相对标准偏差均〈12%。结论:本法是一种简单、快速、准确、灵敏的测定罗库溴铵血药浓度的方法,用于全身麻醉患者靶控输注性能的评价,可以获得较为可靠的结果。 展开更多
关键词 罗库溴铵 液质联用 靶控输注
下载PDF
丙泊酚-雷米芬太尼靶控输注在心脏手术中的应用 被引量:10
15
作者 林霖 李立环 +1 位作者 岳云 于布为 《临床麻醉学杂志》 CAS CSCD 2008年第6期471-472,共2页
目的观察丙泊酚-雷米芬太尼靶控输注(TCI)在心脏瓣膜置换术和冠状动脉旁路移植术中使用的安全性、有效性以及对术后恢复的影响。方法择期心脏手术患者150例,以丙泊酚TCI、雷米芬太尼3~5μg/kg诱导,丙泊酚-雷米芬太尼2~8ng/mlTCI维持,... 目的观察丙泊酚-雷米芬太尼靶控输注(TCI)在心脏瓣膜置换术和冠状动脉旁路移植术中使用的安全性、有效性以及对术后恢复的影响。方法择期心脏手术患者150例,以丙泊酚TCI、雷米芬太尼3~5μg/kg诱导,丙泊酚-雷米芬太尼2~8ng/mlTCI维持,维持脑电双频指数(BIS)于50±10。观察术中血流动力学指标和术后恢复情况。结果所有患者术中血流动力学平稳,术后恢复良好,无术中知晓。结论雷米芬太尼[效应部位浓度(Ce)2~8ng/ml]复合丙泊酚[血浆浓度(Cp)1~2μg/ml]用于心脏手术的麻醉安全有效,血流动力学平稳,有利于术后早期气管拔管。 展开更多
关键词 丙泊酚 靶控输注 血流动力学
下载PDF
瑞芬太尼-丙泊酚联合靶控输注在小儿喉罩麻醉中的应用 被引量:6
16
作者 李娜 林冠文 +3 位作者 刘佳 李秋畅 陈勇 欧阳碧山 《海南医学》 CAS 2014年第18期2681-2684,共4页
目的探讨瑞芬太尼联合丙泊酚联合靶控输注在小儿喉罩麻醉中应用的安全性和可行性。方法选择择期全麻下行腹部手术患儿116例,随机分为瑞芬太尼联合丙泊酚组(A组)和单纯丙泊酚组(B组),每组58例。两组患儿分别静脉输注瑞芬太尼1μg/kg... 目的探讨瑞芬太尼联合丙泊酚联合靶控输注在小儿喉罩麻醉中应用的安全性和可行性。方法选择择期全麻下行腹部手术患儿116例,随机分为瑞芬太尼联合丙泊酚组(A组)和单纯丙泊酚组(B组),每组58例。两组患儿分别静脉输注瑞芬太尼1μg/kg和等容量生理盐水30 s后静注丙泊酚,按照序贯法给予患儿相应的丙泊酚剂量,丙泊酚靶浓度为2.5 mg/kg,后行喉罩插入。观察并记录麻醉诱导前(T0)、瑞芬太尼给药后2 min(T1)、喉罩成功插入即刻(T2)、切皮即刻(T3)、切皮后5 min(T4)和喉罩拔出即刻(T5)患儿的血压(HR)、平均动脉压(MAP)、呼气末二氧化碳分压(PETCO2)和脑电双频谱指数(BIS)以及记录喉罩重新置入的人数、置入时间、术中不良反应。结果与T0时刻比较,B组患儿的HR、MAP在T2、T3、T5时刻均升高(P〈0.01),而A组患儿在各时点HR、MAP差异无统计学意义(P〉0.05)。与B组患儿比较,A组患儿的HR、MAP在T2、T3、T5时刻降低(P〈0.01)。两组患儿PETCO2在T1、T2、T3、T4时刻均高于T0(P〈0.01)。与A组患儿比较,B组患儿BIS在T1~T5时刻均升高(P〈0.01),两组患儿在T1-T5时刻BIS均低于T0(P〈0.01)。A组的患儿喉罩插入后出现咳嗽/作呕、肢体动的例数少于B组(P〈0.05)。结论瑞芬太尼联合丙泊酚靶控输注的麻醉诱导方法能够为患儿喉罩插入提供较好的麻醉条件和较低的不良反应发生率。 展开更多
关键词 瑞芬太尼 丙泊酚 喉罩 靶控输注 小儿
下载PDF
全凭静脉麻醉下镇痛-伤害性刺激指数对于腹腔镜手术疼痛刺激评估的有效性 被引量:7
17
作者 刘军 黄婉 +1 位作者 王卓丹 黎尚荣 《实用医学杂志》 CAS 北大核心 2019年第3期403-406,411,共5页
目的观察气管插管后,腹腔镜手术戳卡置入时,伤害性刺激指数(ANI)与血流动力学变化的相关性,从而评估ANI的有效性。方法本研究为多中心、前瞻临床研究。选取行腹腔镜手术患者284例,患者入室后,完善监护,应用靶控瑞芬太尼和丙泊酚进行麻... 目的观察气管插管后,腹腔镜手术戳卡置入时,伤害性刺激指数(ANI)与血流动力学变化的相关性,从而评估ANI的有效性。方法本研究为多中心、前瞻临床研究。选取行腹腔镜手术患者284例,患者入室后,完善监护,应用靶控瑞芬太尼和丙泊酚进行麻醉诱导完成气管插管,完善动脉穿刺,后采取丙泊酚和瑞芬太尼靶控麻醉维持。记录入室、第一个戳卡完成时及戳卡完成后5 min的ANI数值、动脉收缩压、心率值(研究过程采用电子数据连续记录所需数值)。观察在腹腔镜手术过程中从入室到所有戳卡置入完成后5 min的ANI数值及收缩压(SBP)及心率(HR)变化情况,从而评估ANI指数评估腹腔镜戳卡置入时引起的疼痛的有效性。结果 (1)在切皮-完成所有戳卡后5min的研究时间段内,ANI曲线下面积与SBP、HR曲线下面积呈现正相关性(P <0.05)。(2)在切皮-第一个戳卡置入完成时,ANI与SBP、HR呈负相关性(P <0.001)。结论 ANI的变化与镇痛与伤害性刺激之间平衡关系的变化相一致,与SBP、HR的变化呈负性相关,ANI可以准确的评估戳卡置入时疼痛的情况。 展开更多
关键词 镇痛监测 镇痛-伤害性刺激指数 靶控输注 全身麻醉 瑞芬太尼
下载PDF
右美托咪定复合靶控输注异丙酚-瑞芬太尼用于鼻内镜手术的临床观察 被引量:6
18
作者 张海华 李巧云 谢平 《南昌大学学报(医学版)》 CAS 2013年第10期62-65,共4页
目的探讨右美托咪定复合靶控输注异丙酚-瑞芬太尼用于鼻内镜手术的效果。方法选取择期全身麻醉下行鼻内镜鼻窦开窗术患者80例,ASA分级Ⅰ或Ⅱ级,采用随机数字表法将其分为生理盐水对照组(C组,n=40)和右美托咪定组(D组,n=40)。麻醉诱导前(... 目的探讨右美托咪定复合靶控输注异丙酚-瑞芬太尼用于鼻内镜手术的效果。方法选取择期全身麻醉下行鼻内镜鼻窦开窗术患者80例,ASA分级Ⅰ或Ⅱ级,采用随机数字表法将其分为生理盐水对照组(C组,n=40)和右美托咪定组(D组,n=40)。麻醉诱导前(T0)15 min,D组静脉注射右美托咪定负荷剂量1.0μg·kg-1,继而以0.5μg·kg-1·h-1的速率维持至术毕;C组给予等容量生理盐水。于T0、诱导后即刻(T1)、诱导后20 min(T2)及术毕(T3)时记录心率(HR)、平均动脉压(MAP)、脉搏氧饱和度(SpO2)和警觉镇静评分(OAA/S评分);记录手术时间、异丙酚和瑞芬太尼用量、苏醒时间及不良反应发生情况,并由外科医生按Fromme术野质量评分表进行术野评分(SSFQ评分)。结果与C组比较,D组T1-T3时HR、MAP降低,OAA/S和SSFQ评分降低,异丙酚和瑞芬太尼用量减少,苏醒时间缩短(均P<0.05);SpO2,手术时间,呼吸抑制、心动过缓、恶心呕吐及低血压等不良反应发生率差异无统计学意义(均P>0.05)。结论右美托咪定复合靶控输注异丙酚-瑞芬太尼用于鼻内镜手术血流动力学更稳定,可安全、有效地用于鼻内镜手术。 展开更多
关键词 右美托咪定 异丙酚 瑞芬太尼 靶控输注 鼻内镜手术
下载PDF
瑞芬太尼-丙泊酚靶控输注全麻下腹腔镜胆囊手术的血流动力学变化 被引量:23
19
作者 李懿 黄凝 薛张纲 《中国临床医学》 2012年第3期280-282,共3页
目的:观察瑞芬太尼-丙泊酚靶控输注全麻下腹腔镜胆囊切除术中的血流动力学变化。方法:18例择期腹腔镜胆囊切除术患者,美国麻醉医师协会(American Society of Anesthesiologists,ASA)分级I-II级,入室后即行外周动脉心排量监测,以瑞芬太尼... 目的:观察瑞芬太尼-丙泊酚靶控输注全麻下腹腔镜胆囊切除术中的血流动力学变化。方法:18例择期腹腔镜胆囊切除术患者,美国麻醉医师协会(American Society of Anesthesiologists,ASA)分级I-II级,入室后即行外周动脉心排量监测,以瑞芬太尼-丙泊酚靶控输注复合芬太尼诱导并维持麻醉至手术结束。分别记录手术期间10个时点的心率(HR),平均动脉压(MAP),收缩压(SBP),舒张压(DBP)和外周动脉心功能指数(APCI)。结果:气腹建立后即刻HR增快,DBP升高,APCI明显下降(P<0.05),5min后,DBP进一步升高(P<0.05),SBP、MAP及APCI逐步恢复至气腹前水平且保持相对稳定。气腹解除后即刻HR减慢、DBP降低和APCI升高(P<0.05);5min后MAP、DBP下降(P<0.05),但仍较气腹前高,而HR及APCI恢复气腹前水平。结论:瑞芬太尼-丙泊酚靶控输注全麻下腹腔镜胆囊切除术中,除气腹建立及解除短时间内血流动力学变化较明显外,术中整体血流动力学维持平稳。 展开更多
关键词 瑞芬太尼 丙泊酚 靶控输注 腹腔镜胆囊切除术 血流动力学
下载PDF
小剂量氯胺酮复合丙泊酚-瑞芬太尼静脉麻醉在隆乳术中的应用 被引量:3
20
作者 成丹丹 王志华 +2 位作者 杨岑 栗勇 孙焱芫 《中国美容医学》 CAS 2010年第2期173-175,共3页
目的:观察小剂量氯胺酮复合丙泊酚-瑞芬太尼靶控输注用于隆乳术麻醉的效果和意义。方法:40例患者随机分为丙泊酚复合瑞芬太尼靶控输注组(PR组,n=20)和丙泊酚瑞芬太尼靶控输注联合氯胺酮组(PR-K组,n=20)。两组诱导起始效应室靶浓度相同,P... 目的:观察小剂量氯胺酮复合丙泊酚-瑞芬太尼靶控输注用于隆乳术麻醉的效果和意义。方法:40例患者随机分为丙泊酚复合瑞芬太尼靶控输注组(PR组,n=20)和丙泊酚瑞芬太尼靶控输注联合氯胺酮组(PR-K组,n=20)。两组诱导起始效应室靶浓度相同,PR-K组于诱导时单次静注氯胺酮0.4mg/kg。观察并比较两组患者麻醉效果及血流动力学变化,记录丙泊酚和瑞芬太尼用量。结果:两种麻醉方法均取得较满意的麻醉效果;PR-K组较PR组诱导迅速,血流动力学波动小,且丙泊酚和瑞芬太尼诱导用量少。结论:单次静注小剂量氯胺酮诱导可安全用于隆乳术麻醉,兼具良好的麻醉效应和经济效益。 展开更多
关键词 氯胺酮 麻醉 靶控输注 隆乳术
下载PDF
上一页 1 2 60 下一页 到第
使用帮助 返回顶部